UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7140) 7140
antineoplastic combined chemotherapy protocols - therapeutic use (4590) 4590
female (4387) 4387
male (4278) 4278
vinblastine - administration & dosage (4272) 4272
science & technology (3750) 3750
life sciences & biomedicine (3687) 3687
middle aged (3584) 3584
adult (3436) 3436
aged (2906) 2906
vinblastine - therapeutic use (2874) 2874
oncology (2668) 2668
vinblastine - analogs & derivatives (2462) 2462
biological and medical sciences (2416) 2416
medical sciences (2395) 2395
cisplatin - administration & dosage (2030) 2030
chemotherapy (1990) 1990
pharmacology. drug treatments (1551) 1551
antineoplastic agents (1517) 1517
doxorubicin - administration & dosage (1442) 1442
treatment outcome (1427) 1427
antineoplastic combined chemotherapy protocols - adverse effects (1412) 1412
vinblastine - adverse effects (1370) 1370
lung neoplasms - drug therapy (1361) 1361
bleomycin - administration & dosage (1313) 1313
hodgkin disease - drug therapy (1286) 1286
combined modality therapy (1257) 1257
neoplasm staging (1138) 1138
adolescent (1120) 1120
carcinoma, non-small-cell lung - drug therapy (1041) 1041
antineoplastic agents - therapeutic use (921) 921
vinorelbine (906) 906
prognosis (820) 820
survival rate (790) 790
breast neoplasms - drug therapy (771) 771
vinblastine (757) 757
antineoplastic combined chemotherapy protocols - administration & dosage (755) 755
drug administration schedule (744) 744
abridged index medicus (739) 739
deoxycytidine - analogs & derivatives (730) 730
methotrexate - administration & dosage (730) 730
cancer (712) 712
vincristine - administration & dosage (686) 686
dacarbazine - administration & dosage (679) 679
follow-up studies (673) 673
survival analysis (671) 671
tumors (649) 649
disease-free survival (626) 626
animals (618) 618
cyclophosphamide - administration & dosage (611) 611
prednisone - administration & dosage (601) 601
aged, 80 and over (599) 599
doxorubicin - therapeutic use (592) 592
remission induction (586) 586
deoxycytidine - administration & dosage (581) 581
bleomycin - therapeutic use (575) 575
lung neoplasms - pathology (564) 564
procarbazine - administration & dosage (561) 561
retrospective studies (554) 554
etoposide - administration & dosage (539) 539
hodgkin disease - radiotherapy (531) 531
neoplasm metastasis (526) 526
cisplatin - therapeutic use (523) 523
child (518) 518
drug therapy, combination (513) 513
hodgkin disease - pathology (505) 505
antineoplastic agents, phytogenic - therapeutic use (491) 491
cyclophosphamide - therapeutic use (490) 490
vincristine - therapeutic use (488) 488
urinary bladder neoplasms - drug therapy (477) 477
time factors (460) 460
carcinoma, non-small-cell lung - pathology (442) 442
pharmacology & pharmacy (440) 440
hematology (433) 433
cisplatin - adverse effects (430) 430
testicular neoplasms - drug therapy (427) 427
chemotherapy, adjuvant (417) 417
paclitaxel - administration & dosage (414) 414
prednisone - therapeutic use (405) 405
breast neoplasms - pathology (403) 403
methotrexate - therapeutic use (402) 402
clinical trials as topic (395) 395
cisplatin (385) 385
care and treatment (382) 382
vinblastine - pharmacology (369) 369
dose-response relationship, drug (359) 359
mechlorethamine - administration & dosage (359) 359
carboplatin - administration & dosage (356) 356
bleomycin - adverse effects (355) 355
antineoplastic agents, phytogenic - administration & dosage (353) 353
prospective studies (351) 351
doxorubicin - adverse effects (343) 343
child, preschool (341) 341
carcinoma, transitional cell - drug therapy (338) 338
lung neoplasms - mortality (338) 338
hodgkin disease - mortality (337) 337
mice (334) 334
medicine & public health (327) 327
breast cancer (306) 306
dacarbazine - therapeutic use (306) 306
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6441) 6441
Japanese (382) 382
French (299) 299
German (232) 232
Russian (118) 118
Chinese (89) 89
Italian (86) 86
Spanish (79) 79
Polish (62) 62
Hungarian (18) 18
Czech (12) 12
Hebrew (8) 8
Dutch (7) 7
Bulgarian (5) 5
Portuguese (5) 5
Romanian (4) 4
Serbian (4) 4
Danish (3) 3
Finnish (3) 3
Lithuanian (2) 2
Afrikaans (1) 1
Croatian (1) 1
Icelandic (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology, ISSN 0923-7534, 07/2012, Volume 23, Issue 7, pp. 1818 - 1825
GnRH analogues | ovarian reserve | chemotherapy | fertility | Hodgkin lymphoma | Chemotherapy | Fertility | Ovarian reserve | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Doxorubicin - therapeutic use | Multivariate Analysis | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Gonadotropin-Releasing Hormone - analogs & derivatives | Cyclophosphamide - therapeutic use | Young Adult | Bleomycin - therapeutic use | Menopause - drug effects | Vinblastine - adverse effects | Fertility - drug effects | Follicle Stimulating Hormone - blood | Hodgkin Disease - drug therapy | Adult | Female | Ovary - drug effects | Gonadotropin-Releasing Hormone - therapeutic use | Menstrual Cycle - drug effects | Anti-Mullerian Hormone - blood | Etoposide - adverse effects | Prednisone - adverse effects | Survivors | Etoposide - therapeutic use | Logistic Models | Bleomycin - adverse effects | Randomized Controlled Trials as Topic | Pregnancy | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Ovary - physiopathology | Index Medicus
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Hodgkin's disease | Index Medicus | Abridged Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 08/2014, Volume 25, Issue 8, pp. 1622 - 1628
Journal Article
British journal of haematology, ISSN 0007-1048, 03/2011, Volume 152, Issue 5, pp. 551 - 560
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1015 - 1026
Journal Article
Blood, ISSN 0006-4971, 10/2019, Volume 134, Issue 15, pp. 1238 - 1246
Journal Article
Journal Article
Journal Article